Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
10.11.2003 - 5.12.2003
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2003
Report date:
2003

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
adopted in 1992
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Chemical structure
Reference substance name:
(3S,5S)-5-[(1S,3S)-1-azido-3-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-4-methylpentyl]-3-(propan-2-yl)oxolan-2-one
EC Number:
608-748-5
Cas Number:
324763-46-4
Molecular formula:
C25 H39 N3 O5
IUPAC Name:
(3S,5S)-5-[(1S,3S)-1-azido-3-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-4-methylpentyl]-3-(propan-2-yl)oxolan-2-one

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: albino
Sex:
male/female

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
other: intradermal: olive oil, epicutaneous (induction and challenge): vaseline
Concentration / amount:
Induction - intradermal: 10% test substance in olive oil
Induction - topical application: 50 % test substance in vaseline
Challenge - topical application: 0.5% and 1 % test substance in vaseline
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
other: intradermal: olive oil, epicutaneous (induction and challenge): vaseline
Concentration / amount:
Induction - intradermal: 10% test substance in olive oil
Induction - topical application: 50 % test substance in vaseline
Challenge - topical application: 0.5% and 1 % test substance in vaseline
No. of animals per dose:
treatment group: 10 (4 males and 6 females), control group: 5 (2 males and 3 females)
Details on study design:
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single intradermal injection on Day 0 and 48 h epicutaneous treatment on Day 6
- Test groups:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA/olive oil
Injection 2: 10% of test substance in olive oil
Injection 3: 10% of test substance in a 1:1 mixture (v/v) FCA/olive oil

Epicutaneous: 50% of the test substance in vaseline (24 h before, the skin was pre-treated with 10% sodium lauryl sulphate in vaseline)

- Control group:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA/olive oil
Injection 2: olive oil
Injection 3: olive oil in a 1:1 mixture (v/v) FCA/olive oil

Epicutaneous: vaseline (24 h before, the skin was pre-treated with 10% sodium lauryl sulphate in vaseline)

- Site: shoulder region (intradermal and epicutaneous, respectively)
- Frequency of applications: on Days 0 and 6
- Concentrations: intrdermal 10%, epicutaneous 50%

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day of challenge: 20
- Exposure period: 24 h
- Site: one flank
- Concentrations: 0.5 and 1%
- Evaluation (hr after challenge): 48 and 72 h
Positive control substance(s):
yes
Remarks:
benzocaine

Results and discussion

Positive control results:
The reliability of the experimental technique was checked in intervals of approximately 6 months by testing the positive control substance benzocaine. At the last experiment in August 2003, the positive control substance induced positive reactions in 5/10 animals (50%), thus meeting the reliability criteria for the GPMT test.

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
48
Group:
negative control
Dose level:
0.5% test substance in vaseline
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no clinical observations
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0.5% test substance in vaseline. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no clinical observations.
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
0.5% test substance in vaseline
No. with + reactions:
3
Total no. in group:
10
Clinical observations:
no clinical observations
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.5% test substance in vaseline. No with. + reactions: 3.0. Total no. in groups: 10.0. Clinical observations: no clinical observations.
Reading:
2nd reading
Hours after challenge:
72
Group:
negative control
Dose level:
0.5% test substance in vaseline
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no clinical observations
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 0.5% test substance in vaseline. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no clinical observations.
Reading:
2nd reading
Hours after challenge:
72
Group:
test chemical
Dose level:
0.5% test substance in vaseline
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no clinical observations
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 0.5% test substance in vaseline. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no clinical observations.

Applicant's summary and conclusion

Interpretation of results:
sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
According to REGULATION (EC) No 1272/2008 (CLP) the test substance has to be classified as a skin sensitizer.